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Summary 
 
 Transfer factors are antigen-specific prod-
ucts of T lymphocytes that are capable of 
transferring delayed-type hypersensitivity and 
cell-mediated immunity.  We evaluated bo-
vine transfer factor (TF) for use in receiving 
cattle.  Crossbred beef heifers (n = 665) ini-
tially weighing 495 lb were used to determine 
the effects of TF on the health and perform-
ance of beef cattle during a 36-day receiving 
period.  Heifers were processed within 24 
hours after arrival.  Treatments were subcuta-
neous injection with 1.5 ml of Micotil®/100 lb 
of body weight or oral administration of 700 
mg of TF isolated from bovine colostrum.  
Heifers given TF during initial processing re-
ceived an additional 700 mg/day of TF in the 
diet on days 2 through 5.   The percentage of 
heifers treated at least one, two, or three times 
for bovine respiratory disease (BRD) was 
greater (P<0.01) for heifers given TF than for 
heifers given Micotil (72.5 vs. 47.1; 31.5 vs. 
14.7; and 18.0 vs. 4.2, respectively).  There 
were no differences between TF and Micotil 
with respect to dry matter intake, weight gain, 
or gain efficiency of heifers.  Subsequent in 
vitro fermentations indicated that TF protein is 
readily degraded by ruminal microbes.  Oral 
administration of TF was not as effective as 
Micotil injection in decreasing BRD in receiv-
ing cattle.  
 
Introduction 
 
 Bovine respiratory disease (BRD) is the 
leading cause of morbidity and mortality in 
feedlot cattle.  Treatment for BRD in feedlot 
cattle generally uses antibiotic therapy, which 
fosters public concern about antibiotic usage 
in livestock.  Transfer factors are products of 
T lymphocytes, seem to consist entirely of 
protein, and are rather small. Transfer factors 
are antigen specific and possess the ability to 
transfer delayed-type hypersensitivity and 
cell-mediated immunity from an individual 
previously exposed to a specific antigen to a 
naïve recipient; but data is lacking about ef-
fects of oral administration of transfer factors 
in functional ruminants. 
 
 The objective of our experiment was to 
compare oral administration of transfer factors 
with the antibiotic Micotil as a prophylactic 
treatment against BRD in receiving cattle.  We 
also characterized degradation of transfer fac-
tor protein by ruminal microbes in vitro. 
 
Experimental Procedures 
 
 Experiment 1.  A total of 665 crossbred 
beef heifers initially weighing 495 lb was used 
in a completely randomized design to deter-
mine the effects of bovine transfer factor (TF) 
on the health and performance of beef cattle 
during a 36-day receiving period.  Heifers 
were processed within 24 hours after arrival, 
and processing included measurement of body 
weight, vaccination against common viral and 
clostridial diseases (Bovishield® 4 and For-
tress® 7, respectively), recording of rectal 
temperature, and treatment for internal and 
external parasites (Phoenectin®).  In addition, 
heifers received either a subcutaneous injec-
tion of 1.5 ml of Micotil/100 lb of body 
weight or received 50 ml of a solution consist-
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ing of water and 28 grams of a commercially 
available source of TF isolated from bovine 
colostrom (Livestock Stress FormulaTM).  The 
TF solution was administered orally via dose 
syringe to provide 700 mg of actual TF.  Im-
mediately after initial processing, heifers 
within each treatment were assigned randomly 
among 28 pens.  Pens contained 21 to 27 heif-
ers each, depending upon pen size, with 14 
pens per treatment.  Heifers given TF during 
initial processing received an additional 28 
grams of Livestock Stress Formula daily in the 
diet as a top dress on days 2 through 5.  Heif-
ers were subsequently monitored for clinical 
signs of BRD, including depression, lethargy, 
anorexia, coughing, rapid breathing, and nasal 
or ocular discharge.  Heifers exhibiting signs 
of BRD received antibiotic therapy consisting 
of Micotil as a first-time and second-time 
treatment for BRD, and Liquamycin® LA-
200® and dexamethasone as a third-time 
treatment for BRD. The number of times heif-
ers were treated for BRD ranged between zero 
and three. Heifers were offered a common re-
ceiving diet for ad libitum consumption once 
daily (Table 1).  At the end of the 36-day re-
ceiving period, heifers were weighed. 
 
Table 1.  Diet Composition for Experiment 1 
(% of Dry Matter) 
 
Ingredient 
% of 
Dry Matter 
Steam-flaked corn 44.0 
Alfalfa hay 45.0 
Corn steep liquor 6.0 
Soybean meal 3.8 
Salt 0.4 
Potassium chloride 0.2 
Vitamin/trace mineral premixa 0.6 
  
Chemical composition, analyzed  
Dry matter 81.5 
Crude protein 17.0 
aFormulated to provide the following (dry matter 
basis): 1,500 IU/lb vitamin A, 20 IU/lb vitamin E, 
0.1 ppm cobalt, 10 ppm copper, 0.63 ppm iodine, 
60 ppm manganese, 0.3 ppm selenium, 2 ppm 
iron, and 60 ppm zinc. 
 Experiment 2.  In vitro incubations of 
rumen fluid alone (control), with casein, or 
with TF were conducted.  Whole rumen con-
tents were obtained from two ruminally can-
nulated steers fed a diet containing (dry matter 
basis) 76% steam-flaked corn, 10% alfalfa 
hay, 3% soybean meal, 1.2% urea, 5% cane 
molasses, and 4.8% of a mineral vitamin pre-
mix offered for ad libitum consumption.  Ru-
minal contents were strained through two lay-
ers of cheesecloth, and mixed with buffer, and 
200 ml of the rumen fluid/buffer mixture were 
added to flasks containing no added protein 
(control) or containing 40 mg of nitrogen from 
either casein or Livestock Stress Formula.  
Flasks were incubated for 1.5 hours at 102°F, 
and a 1-ml sample from each flask was col-
lected every 30 minutes.  Products of protein 
degradation were measured in the resulting 
samples. Twelve flasks were used, providing 
four replications per treatment. 
 
Results and Discussion 
 
 Experiment 1.  Heifers that received Mi-
cotil during initial processing required fewer 
first-time, second-time, and third-time treat-
ment for BRD (P<0.01) compared with heifers 
receiving TF (Table 2), suggesting that Mico-
til was more effective as a prophylactic treat-
ment against BRD than TF.  The percentage 
death loss for heifers receiving Micotil was 
1.1% and for those receiving TF was 1.0%; 
this was not different between treatments.   
 
 Treatment did not affect dry matter intake, 
average daily gain, or gain efficiency of heif-
ers during the receiving period (Table 2), in 
spite of differences in the percentage of heif-
ers treated for BRD.  
 
 Experiment 2.  Rate of in vitro protein 
degradation was greater for TF than for casein 
(Figure 1). Casein is commonly used as a 
standard for measuring protein degradability, 
and it is rapidly and extensively degraded by 
ruminal microbes. The TF protein was de-
graded at a greater rate than casein, indicating 
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that TF protein is rapidly degraded by ruminal 
microbes. Degradation of TF protein by ru-
minal microbes might have contributed to the 
failure of TF to protect against BRD as effec-
tively as Micotil in our experiment.   
 
 The results of these experiments suggest 
that orally administering TF as a prophylactic 
treatment against BRD in cattle is not as effec-
tive as prophylactic medication with Micotil, 
possibly because of extensive degradation of 
TF protein by ruminal microbes. 
 
 
 
Table 2.  Treatment Incidence for Bovine Respiratory Disease (BRD), Percentage Death 
Loss, and Growth Performance of Newly Arrived Heifers After Prophylactic Treatment 
with Either Micotil® or Bovine Transfer Factor  
Item Micotil Transfer Factor SEM P-value 
No. of pens 14 14 - - 
No. of heifers 333 332 - - 
Initial body weight, lb 493 495 6.2 0.71 
Final body weight, lb 594 596 11.2 0.88 
Treatments for BRD, % of heifers     
at least one 47.1 72.5 3.6 <0.01 
at least two 14.7 31.5 3.5 0.01 
three 4.2 18.0 2.3 0.01 
Death loss, % 1.1 1.0 0.57 0.88 
Dry matter intake, lb/day 12.5 12.3 0.37 0.73 
Dry matter intake, % of body weight daily 2.31 2.26 0.05 0.47 
Daily gain, lb 2.79 2.77 0.19 0.92 
Gain:feed 0.220 0.221 0.011 0.95 
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Figure 1.  Rates of In Vitro Protein Degradation.  Effect of protein source (P<0.05). 
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